1. 1.Kong D, Lee MJ, Lin S*, Kim ES*. Biosynthesis and pathway engineering of antifungal polyene macrolides in actinomycetes. J Ind Microbiol Biotechnol,2013, 40(6):529-43.
2. 2. Lin S, Huang T, Shen B*. Tailoring enzymes acting on carrier protein-tethered substrates in natural product biosynthesis. Methods Enzymol, 2012, 516:321-43.
3. 3. Lin S, Huang T, Horsman GP, Huang SX, Guo X, Shen B*. Specificity of the ester bond forming condensation enzyme SgcC5 in C-1027 biosynthesis. Org Lett, 2012, 14(9):2300-3.
4. 4.Lin S, Horsman GP, Shen B*. Characterization of the epoxide hydrolase NcsF2 from the neocarzinostatin biosynthetic gene cluster. Org Lett, 2010, 12(17):3816-3819.
5. 5.Lin S, Van Lanen SG and Shen B*. A free-standing condensation enzyme catalyzing ester bond formation in C-1027 biosynthesis. Proc. Natl. Acad. Sci. U.S.A, 2009, 106(11):4183-4188.
7. 7. Lin S, Van Lanen SG, Shen B*.Characterization of the two-component, FAD-dependent monooxygenase SgcC that requires carrier protein-tethered substrates for the biosynthesis of the enediyne antitumor antibiotic C-1027. J Am Chem Soc, 2008, 130(20):6616-6623.
8. 8.Van Lanen SG, Lin S, Shen B*. Biosynthesis of the enediyne antitumor antibiotic C-1027 involves a new branching point in chorismate metabolism. Proc. Natl. Acad. Sci. U.S.A, 2008, 105(2):494-499.
9. 9.Lin S, Van Lanen SG, Shen B*. Regiospecific chlorination of (S)-beta-tyrosyl-S-carrier protein catalyzed by SgcC3 in the biosynthesis of the enediyne antitumor antibiotic C-1027. J Am Chem Soc, 2007, 129(41):12432-12438.